申请人:Ericson Anna M.
公开号:US20120053345A1
公开(公告)日:2012-03-01
Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I)
wherein the substituents are as defined herein, which are useful as therapeutic agents.
本发明涉及化合物(I)或其药学上可接受的盐、前药和生物活性代谢物,其中取代基的定义如本文所述,这些化合物可用作治疗剂。